Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
E
183490
vs
K
KOSPI 200
Over the past 12 months, Enzychem Lifesciences Corp has underperformed KOSPI 200, delivering a return of -14% compared to KOSPI 200's +125% growth.
Stocks Performance
183490 vs KOSPI 200
Performance Gap
183490 vs KOSPI 200
Performance By Year
183490 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Enzychem Lifesciences Corp
Glance View
ENZYCHEM LIFESCIENCES Corp. engages in developing, manufacturing, and distributing pharmaceutical products. The company is headquartered in Jecheon, Chungcheongbuk-Do. The company went IPO on 2013-09-25. The firm provides D-cycloserine, a synthetic product utilizing chiral technology to treat tuberculosis; antibiotics, such as terizidone, cefbuperazone, cefazedone and others; magnetic resonance imaging (MRI) contrast agents such as gadoterate and gadopentate; others for antithrombotic drugs, antiinflammatory analgesic drugs, and drugs for gastric ulcer and hyperlipidemia. The firm also provides functional health food and finished drug products.